NO20001569L - Bisethers of 1-oxa, aza and thianaphthalene-2-ones as phospholamban inhibitors - Google Patents
Bisethers of 1-oxa, aza and thianaphthalene-2-ones as phospholamban inhibitorsInfo
- Publication number
- NO20001569L NO20001569L NO20001569A NO20001569A NO20001569L NO 20001569 L NO20001569 L NO 20001569L NO 20001569 A NO20001569 A NO 20001569A NO 20001569 A NO20001569 A NO 20001569A NO 20001569 L NO20001569 L NO 20001569L
- Authority
- NO
- Norway
- Prior art keywords
- bisethers
- thianaphthalene
- aza
- oxa
- ones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93711997A | 1997-09-24 | 1997-09-24 | |
| US99015097A | 1997-12-12 | 1997-12-12 | |
| US10411498A | 1998-06-25 | 1998-06-25 | |
| PCT/FI1998/000755 WO1999015523A1 (en) | 1997-09-24 | 1998-09-24 | Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001569L true NO20001569L (en) | 2000-03-24 |
| NO20001569D0 NO20001569D0 (en) | 2000-03-24 |
Family
ID=27379660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001569A NO20001569D0 (en) | 1997-09-24 | 2000-03-24 | Bisethers of 1-oxa, aza and thianaphthalene-2-ones as phospholamban inhibitors |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1017691A1 (en) |
| JP (1) | JP2003525838A (en) |
| KR (1) | KR20010015607A (en) |
| CN (1) | CN1143857C (en) |
| AU (1) | AU735729B2 (en) |
| BR (1) | BR9813216A (en) |
| CA (1) | CA2304849A1 (en) |
| EA (1) | EA003084B1 (en) |
| EE (1) | EE04494B1 (en) |
| HU (1) | HUP0003647A3 (en) |
| ID (1) | ID24373A (en) |
| IL (1) | IL134662A0 (en) |
| NO (1) | NO20001569D0 (en) |
| NZ (1) | NZ503044A (en) |
| PL (1) | PL339493A1 (en) |
| SK (1) | SK3902000A3 (en) |
| TR (1) | TR200000764T2 (en) |
| WO (1) | WO1999015523A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001278980A1 (en) | 2000-07-21 | 2002-02-05 | Chugai Seiyaku Kabushiki Kaisha | Coumarin derivatives useful as tnfalpha inhibitors |
| AU2002226634B2 (en) * | 2001-03-30 | 2007-01-25 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| FR2970964B1 (en) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | NOVEL AZACOUMARIN DERIVATIVES WITH INHIBITOR ACTIVITY OF MDR PUMPS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543945A1 (en) * | 1975-10-02 | 1977-04-21 | Troponwerke Gmbh & Co Kg | Coronary dilator 2-benzopyranones, active by enteral admin. - contg. trimethoxybenzoyl or trimethoxycinnamoyl substits. |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8630702D0 (en) * | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
| EP0355583B1 (en) * | 1988-08-10 | 1995-01-25 | Otsuka Pharmaceutical Co., Ltd. | Cardiotonics |
| IE902750A1 (en) * | 1989-07-31 | 1991-02-27 | Sankyo Co | Coumarin derivatives, their preparation and their use in the¹treatment of cerebrovascular disorders |
| DE4337906A1 (en) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Use of coumarin derivatives |
-
1998
- 1998-09-24 AU AU93508/98A patent/AU735729B2/en not_active Ceased
- 1998-09-24 WO PCT/FI1998/000755 patent/WO1999015523A1/en not_active Application Discontinuation
- 1998-09-24 CN CNB98809438XA patent/CN1143857C/en not_active Expired - Fee Related
- 1998-09-24 SK SK390-2000A patent/SK3902000A3/en unknown
- 1998-09-24 ID IDW20000564A patent/ID24373A/en unknown
- 1998-09-24 IL IL13466298A patent/IL134662A0/en unknown
- 1998-09-24 EA EA200000352A patent/EA003084B1/en not_active IP Right Cessation
- 1998-09-24 PL PL98339493A patent/PL339493A1/en unknown
- 1998-09-24 JP JP2000512828A patent/JP2003525838A/en active Pending
- 1998-09-24 TR TR2000/00764T patent/TR200000764T2/en unknown
- 1998-09-24 HU HU0003647A patent/HUP0003647A3/en unknown
- 1998-09-24 BR BR9813216-4A patent/BR9813216A/en not_active IP Right Cessation
- 1998-09-24 NZ NZ503044A patent/NZ503044A/en unknown
- 1998-09-24 CA CA002304849A patent/CA2304849A1/en not_active Abandoned
- 1998-09-24 EP EP98946482A patent/EP1017691A1/en not_active Withdrawn
- 1998-09-24 KR KR1020007003094A patent/KR20010015607A/en not_active Application Discontinuation
- 1998-09-24 EE EEP200000179A patent/EE04494B1/en not_active IP Right Cessation
-
2000
- 2000-03-24 NO NO20001569A patent/NO20001569D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU735729B2 (en) | 2001-07-12 |
| AU9350898A (en) | 1999-04-12 |
| SK3902000A3 (en) | 2000-12-11 |
| CN1143857C (en) | 2004-03-31 |
| TR200000764T2 (en) | 2001-03-21 |
| BR9813216A (en) | 2000-08-29 |
| JP2003525838A (en) | 2003-09-02 |
| IL134662A0 (en) | 2001-04-30 |
| HUP0003647A3 (en) | 2002-12-28 |
| CN1271357A (en) | 2000-10-25 |
| EA200000352A1 (en) | 2000-10-30 |
| PL339493A1 (en) | 2000-12-18 |
| HUP0003647A2 (en) | 2001-08-28 |
| KR20010015607A (en) | 2001-02-26 |
| ID24373A (en) | 2000-07-13 |
| EE04494B1 (en) | 2005-06-15 |
| EP1017691A1 (en) | 2000-07-12 |
| NO20001569D0 (en) | 2000-03-24 |
| WO1999015523A1 (en) | 1999-04-01 |
| EA003084B1 (en) | 2002-12-26 |
| NZ503044A (en) | 2001-08-31 |
| EE200000179A (en) | 2001-04-16 |
| CA2304849A1 (en) | 1999-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005928L (en) | Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation | |
| HK1044545A1 (en) | Human beta-secretase enzyme, inhibitors and their compositions and uses | |
| NO20002162D0 (en) | Tienopyrimidine and thienopyridine derivatives useful as anticancer agents | |
| DK1105123T3 (en) | Pharmaceuticals containing lipase inhibitors and chitosan | |
| NO983187L (en) | Substituted aza and diazacycloheptane and cyclooctane compound and their use | |
| ZA200306490B (en) | Inhibitors of factor Xa. | |
| NO991922D0 (en) | Heteroarlsuccinamides and their use as metalloproteinase inhibitors | |
| NO20011216D0 (en) | Acetidine derivatives, manufacture and medications containing these | |
| DK0944590T3 (en) | Aminoguanidines and alkoxyguanidines as protease inhibitors | |
| AU7294098A (en) | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses | |
| PT956294E (en) | TROMBIN INHIBITORS | |
| NO20002181D0 (en) | Sterilization wrap, its use and method of sterilization | |
| DK1023268T3 (en) | Isoquinolines as urokinase inhibitors. | |
| NO995513L (en) | N-triazolyl-2-indolecarboxamides and their use as CCK- | |
| HK1020741A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| DK1214302T3 (en) | Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones and their use as lipase inhibitors | |
| DE60024101D1 (en) | ENZYME INHIBITORS | |
| NO20004904L (en) | C11 oxymyl and hydroxylaminoprostaglandins useful as medicaments | |
| TR199501644A2 (en) | Squalene synthase inhibitors. | |
| NO20001569L (en) | Bisethers of 1-oxa, aza and thianaphthalene-2-ones as phospholamban inhibitors | |
| DE60020583D1 (en) | SYNCHRONIZATION OF PCM AND PSEUDOZUFALLSTAKTGEBERN | |
| NO984647D0 (en) | Specific immunophilin ligands such as antiastmatics and immunosuppressants | |
| NO20001176D0 (en) | Use of blends of polymers and aminoisothiazoles as biocides | |
| DK1224254T3 (en) | Enzymatic graying inhibitor | |
| ZA200105277B (en) | New amidinobenzylamine derivatives and their use as thrombin inhibitors. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |